Vulvodynia: Strategies for treatment

Clinical Obstetrics and Gynecology

Volumn 48, Issue 4, 2005, Pages 769-785

  Goldstein, Andrew T ^a   Marinoff, Stanley C ^b   Haefner, Hope K ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANTIFUNGAL AGENT; ATROPINE; BACLOFEN; BENZOCAINE; BOTULINUM TOXIN; CAPSAICIN; CARBAMAZEPINE; CITALOPRAM; CONJUGATED ESTROGEN; CORTICOSTEROID; DESIPRAMINE; DIPHENHYDRAMINE; EMLA; ESTRADIOL; ESTROGEN; FLUOXETINE; GABAPENTIN; GLYCERYL TRINITRATE; LIDOCAINE; NORTRIPTYLINE; PAROXETINE; PETROLATUM; PRILOCAINE; SERTRALINE; TESTOSTERONE; TOPIRAMATE; TRAMADOL; TRAUMEEL; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VAGICAINE; VAGISIL; VENLAFAXINE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACUPUNCTURE; AGRANULOCYTOSIS; ALGORITHM; ALLERGIC RASH; ANAPHYLAXIS; ANEMIA; ANGIONEUROTIC EDEMA; ANOREXIA; ANXIETY; APLASTIC ANEMIA; ASTHENIA; ASTHMA; ATAXIA; BLURRED VISION; BREAST DISEASE; BRONCHOSPASM; CONFUSION; CONSTIPATION; CONTACT DERMATITIS; DEPRESSION; DIAPHORESIS; DIARRHEA; DIET SUPPLEMENTATION; DIPLOPIA; DIZZINESS; DROWSINESS; DYSMENORRHEA; EDEMA; EPIDERMOLYSIS; ERYTHEMA; ERYTHEMA MULTIFORME; EUPHORIA; FATIGUE; FEEDBACK SYSTEM; FLUID RETENTION; GALLBLADDER DISEASE; GLAUCOMA; HALLUCINATION; HEADACHE; HEART INFARCTION; HEPATITIS; HUMAN; HYPERTENSION; HYPERTHERMIA; HYPONATREMIA; HYPOTENSION; KIDNEY TUBULE ACIDOSIS; LEUKOPENIA; LIVER FAILURE; MASTALGIA; MENTAL INSTABILITY; METABOLIC ACIDOSIS; MOOD CHANGE; MYOPIA; NAUSEA; NEPHROLITHIASIS; NERVOUSNESS; NYSTAGMUS; OBSTRUCTIVE JAUNDICE; PALLOR; PANCREATITIS; PANCYTOPENIA; PARESTHESIA; PATHOLOGY; PHYSIOTHERAPY; PORPHYRIA; PSYCHOMOTOR RETARDATION; PURPURA; RASH; RESPIRATION DEPRESSION; REVIEW; RHINITIS; SEIZURE; SEROTONIN SYNDROME; SIDE EFFECT; SKIN IRRITATION; SOMNOLENCE; SPASTICITY; SPOTTING; STEVENS JOHNSON SYNDROME; STROKE; SUDDEN DEATH; SUICIDAL IDEATION; SURGICAL TECHNIQUE; SWEATING; SYNCOPE; TACHYCARDIA; THROMBOCYTOPENIA; THROMBOEMBOLISM; TINNITUS; TOPICAL ANESTHESIA; TREMOR; URINE RETENTION; VAGINA BLEEDING; VASODILATATION; VISUAL DISORDER; VOMITING; VULVODYNIA; WATER INTOXICATION; WEAKNESS; WEIGHT CHANGE; WEIGHT GAIN; XEROSTOMIA;

ALGORITHMS; FEMALE; HUMANS; PAIN; VULVAR DISEASES;

EID: 29544453109     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.grf.0000182213.21599.49     Document Type: Review

References (33)

1. Jones KD, Lehr ST. Vulvodynia: diagnostic techniques and treatment modalities. Nurse Pract. 1994;19:34, 37-46.
2. Goetsch MF. Vulvar vestibulitis: prevalence and historic features in a general gynecologic practice population. Am J Obstet Gynecol. 1991;164:1609-1614; discussion 1614-1616.
3. Denbow ML, Byrne MA. Prevalence, causes and outcome of vulval pain in a genitourinary medicine clinic population. Int J STD AIDS. 1998;9:88-91.
4. Danielsson I, Sjoberg I, Stenlund H, et al. Prevalence and incidence of prolonged and severe dyspareunia in women: results from a population study. Scand J Public Health. 2003;31:113-118.
5. Boardman LA, Peipert JF. Vulvar vestibulitis: is it a defined and treatable entity? Clin Obstet Gynecol. 1999;42:945-956.
6. Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc. 2003;58:82-88.
7. Resident Population Estimates of the United States by Age and Sex. April 1, 1990-July 1, 1999. Washington, DC: Population Estimates Program, Population Division, US Census Bureau; 2000.
8. Reed BD, Crawford S, Couper M, et al. Pain at the vulvar vestibule: a web-based survey. Journal of Lower Genital Tract Disease. 2004;8:48-57.
9. Edwards L. New concepts in vulvodynia. Am J Obstet Gynecol. 2003;189(Suppl):S24-S30.
10. Prayson RA, Stoler MH, Hart WR. Vulvar vestibulitis. A histopathologic study of 36 cases, including human papillomavirus in situ hybridization analysis. Am J Surg Pathol. 1995;19:154-160.
11. Bergeron C, Moyal-Barracco M, Pelisse M, et al. Vulvar vestibulitis. Lack of evidence for a human papilloma virus etiology. J Reprod Med. 1994;39:936-938.
12. Chadha S, Gianotten WL, Drogendijk AC, et al. Histopathologic features of vulvar vestibulitis. Int J Gynecol Pathol. 1998;17:7-11.
13. Morin C, Bouchard C, Brisson J, et al. Human papillomaviruses and vulvar vestibulitis. Obstet Gynecol. 2000;95:683-687.
14. Friedman M, Siegler E, Kerner H. Clinical and histopathological changes of the vulvar vestibulum in healthy subjects and in patients with vulvar vestibulitis. XII International Congress of the International Society for the Study of Vulvar Disease, Quebec City, Canada 1993, Abstracts p. 21.
15. Bohm-Starke N, Hilliges M, Falconer C, et al. Increased intraepithelial innervation in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest. 1998;46:256-260.
16. Pukall CF, Binik YM, Khalife S, et al. Vestibular tactile and pain thresholds in women with vulvar vestibulitis syndrome. Pain. 2002;96:163-175.
17. Gordon AS, Panahian-Jand M, McComb F, et al. Characteristics of women with vulvar pain disorders: responses to a Web-based survey. J Sex Marital Ther. 2003;29(Suppl 1):45-58.
18. Eide PK. Wind-up and the NMDA receptor complex from a clinical perspective. Eur J Pain. 2000;4:5-15.
19. Eva LJ, MacLean AB, Reid WM, et al. Estrogen receptor expression in vulvar vestibulitis syndrome. Am J Obstet Gynecol. 2003;189:458-461.
20. Peckham BM, Maki DG, Patterson JJ, et al. Focal vulvitis: a characteristic syndrome and cause of dyspareunia. Features, natural history, and management. Am J Obstet Gynecol. 1986;154:855-864.
21. Zolnoun DA, Hartmann KE, Steege JF. Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol. 2003;102:84-87.
22. Yamashita S, Sato S, Kakiuchi Y, et al. Lidocaine toxicity during frequent viscous lidocaine use for painful tongue ulcer. J Pain Symptom Manage. 2002;24:543-545.
23. Munday PE. Response to treatment in dysaesthetic vulvodynia. J Obstet Gynaecol. 2001;6:610-613.
24. Hartmann EH, Nelson C. The perceived effectiveness of physical therapy treatment on women complaining of chronic vulvar pain and diagnosed with either vulvar vestibulitis syndrome or dysesthetic vulvodynia. J Sect Womens Health. 2001;25:13-18.
25. Bergeron S, Brown C, Lord MJ, et al. Physical therapy for vulvar vestibulitis syndrome: a retrospective study. J Sex Marital Ther. 2002;28:183-192.
26. Goldstein A, Davies-Treene L, Hurtado S, et al. Interferon alpha therapy for vulvar vestibulitis syndrome: a large retrospective trial. Presented at the International Society for the Study of Women's Sexual Health Conference, Vancouver, BC, October 2002.
27. Solomons CC, Melmed MH, Heitler SM. Calcium citrate for vulvar vestibulitis. A case report. J Reprod Med. 1991;36:879-882.
28. Yount JJ, Solomons CC, Willems JJ, et al. Effective nonsurgical treatments for vulvar pain. Women's Health Digest. 1997;3:88-93.
29. Baggish MS, Sze EH, Johnson R. Urinary oxalate excretion and its role in vulvar pain syndrome. Am J Obstet Gynecol. 1997;177:507-511.
30. Haefner HK. Critique of new gynecologic surgical procedures: surgery for vulvar vestibulitis. Clin Obstet Gynecol. 2000;43:689-700.
31. Bornstein J, Zarfati D, Goldik Z, et al. Vulvar vestibulitis: physical or psychosexual problem? Obstet Gynecol. 1999;93:876-880.
32. Bornstein J, Zarfati D, Goldik Z, et al. Perineoplasty compared with vestibuloplasty for severe vulvar vestibulitis. Br J Obstet Gynaecol. 1995;102:652-655.
33. Haefner HK, Collins ME, Davis GD, et al. The vulvodynia guideline. Journal of Lower Genital Tract Disease. 2005;9:40-51.